tyler-smith.com · Questions & Answers

A strategic competitor is offering an eight-times EBITDA valuation based on expected sales synergies, while a financial sponsor offers six-times with an equity rollover. How do we calculate the true risk-adjusted proceeds to avoid taking a headline price that collapses during due diligence?

Never confuse a high headline price with walkaway cash. Strategic buyers routinely float inflated multiples during early indications of interest because they model aggressive cost synergies, such as eliminating your sales leadership, closing facilities, and consolidating software stacks. Financial sponsors offer lower headline multiples based solely on historical standalone cash flow, but their capital structure and path to close are often far more reliable.

To evaluate the offers objectively, run a risk-adjusted comparison across three critical levers:

- Net cash at close after transaction adjustments. Strip out hypothetical earnouts, seller notes, and escrow holdbacks. A six-times multiple that delivers eighty-five percent cash at close often nets more certainty than an eight-times multiple that requires a thirty percent performance earnout tied to post-merger integration.
- Confirmatory due diligence vulnerability. Strategic buyers weaponize the due diligence window to chip away at your valuation once they review operational redundancies. If their synergy thesis requires firing half your admin team, they may re-trade the purchase price if your operational processes are not completely codified.
- The second bite at the apple. A financial sponsor requiring a ten to twenty percent equity rollover allows you to cash out the majority of your wealth today while participating in their future platform recapitalization. If they double enterprise value in four years, that rollover equity can yield a total return that dwarfs the competitor's eight-times initial offer.

Use your Vision/Traction Organizer to determine your true financial target. If the cash component of the sponsor's offer clears your number, prioritizing closing certainty over speculative synergy multiples is the disciplined move.

Category: Valuation & Deal Structure

← All questions